In just two years, Australia’s complementary medicines industry has grown from A$2.3bn (US$1.7bn) to A$4.2bn (US$3.1), with increasing acceptance and demand from consumers, both at home and abroad.
New research has shown for the first time that the part of the brain used for learning, memory and mental health is smaller in people with unhealthy diets.
The representative body for the complementary medicines industry has responded to the government’s medicines review by calling for regulation that reflects risk, protects consumers, safeguards quality and promotes industry best practice.
Business confidence is strong within Australia’s complementary healthcare segment with more than eight out of 10 companies expecting to see their businesses grow over the next three years.
Australia’s leading complementary healthcare association has slammed the government for snubbing it while appointing the new Therapeutic Goods Advisory Council (TGAC).